Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early recovery of botulism: one decade of experience.
Hatami F, Shokouhi S, Mardani M, Shabani M, Gachkar L, Alavi Darazam I. Hatami F, et al. Among authors: mardani m. Clin Toxicol (Phila). 2021 Jul;59(7):628-632. doi: 10.1080/15563650.2020.1844225. Epub 2020 Nov 6. Clin Toxicol (Phila). 2021. PMID: 33156710
An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized controlled trial.
Alavi Darazam I, Hatami F, Mahdi Rabiei M, Amin Pourhoseingholi M, Shabani M, Shokouhi S, Mardani M, Moradi O, Javandoust Gharehbagh F, Mirtalaee N, Negahban H, Amirdosara M, Zangi M, Hajiesmaeili M, Kazempour M, Shafigh N. Alavi Darazam I, et al. Among authors: mardani m. Int Immunopharmacol. 2021 Oct;99:107916. doi: 10.1016/j.intimp.2021.107916. Epub 2021 Jun 29. Int Immunopharmacol. 2021. PMID: 34224994 Free PMC article. Clinical Trial.
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial.
Alavi Darazam I, Shokouhi S, Mardani M, Pourhoseingholi MA, Rabiei MM, Hatami F, Shabani M, Moradi O, Gharehbagh FJ, Irvani SSN, Amirdosara M, Hajiesmaeili M, Rezaei O, Khoshkar A, Lotfollahi L, Gachkar L, Dehbsneh HS, Khalili N, Soleymaninia A, Kusha AH, Shoushtari MT, Torabinavid P. Alavi Darazam I, et al. Among authors: mardani m. Int Immunopharmacol. 2021 Oct;99:107969. doi: 10.1016/j.intimp.2021.107969. Epub 2021 Jul 10. Int Immunopharmacol. 2021. PMID: 34273635 Free PMC article. Review.
Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19.
Shabani M, Totonchi M, Rezaeimirghaed O, Gachkar L, Hajiesmaeili M, Khoshkar A, Amirdosara M, Saffaei A, Shokouhi S, Mardani M, Alavi Darazam I, Karami A, Sharifi M, Zaman M, Abedheydari E, Sahraei Z. Shabani M, et al. Among authors: mardani m. Pulm Pharmacol Ther. 2021 Oct;70:102069. doi: 10.1016/j.pupt.2021.102069. Epub 2021 Aug 10. Pulm Pharmacol Ther. 2021. PMID: 34389507 Free PMC article.
Study of the effects of interferon β-1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study.
Fallahzadeh M, Pourhoseingholi MA, Boroujeni MG, Besharati S, Mardani M, Shabani M, Shokouhi S, Amirdosara M, Hajiesmaeili M, Gachkar L, Roshan B, Zangi M, Mirmomeni G, Irvani SSN, Alavi Darazam I. Fallahzadeh M, et al. Among authors: mardani m. J Med Virol. 2022 Apr;94(4):1488-1493. doi: 10.1002/jmv.27475. Epub 2021 Nov 30. J Med Virol. 2022. PMID: 34821387 Free PMC article.
241 results